General Information of the Compound
Compound ID
CP0222355
Compound Name
6-[[6-(3,4-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline
    Show/Hide
Structure
Formula
C21H13F2N5
Molecular Weight
373.366
Canonical SMILES
Fc1ccc(cc1F)-c1ccc2nnc(Cc3ccc4ncccc4c3)n2n1
    Show/Hide
InChI
InChI=1S/C21H13F2N5/c22-16-5-4-15(12-17(16)23)19-7-8-20-25-26-21(28(20)27-19)11-13-3-6-18-14(10-13)2-1-9-24-18/h1-10,12H,11H2
    Show/Hide
InChIKey
QRFFCWZXJYGMRK-UHFFFAOYSA-N
Physicochemical Property
logP
4.2085
Rotatable Bonds
3
Heavy Atom Count
28
Polar Areas
55.97
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24965874
SID: 56263997
ChEMBL ID
CHEMBL2431839
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000068 A-549 Homo sapiens (Human)  1
1
IC50 = 48 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 44 nM